{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T12:05:31Z","timestamp":1779537931683,"version":"3.53.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-025-11405-1","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T13:26:41Z","timestamp":1763731601000},"page":"4555-4564","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nitroquinolones and nitroquinolines: syntheses and antitrypanosomal activity"],"prefix":"10.1007","volume":"30","author":[{"given":"Phelelisiwe S.","family":"Dube","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol R.","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesetja J.","family":"Legoabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie Uli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina P.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor R.","family":"Caffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Beteck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"4","key":"11405_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1021\/acsmedchemlett.9b00566","volume":"11","author":"J Pedron","year":"2020","unstructured":"Pedron J et al (2020) New 8-nitroquinolinone derivative displaying submicromolar in vitro activities against both Trypanosoma brucei and cruzi. ACS Med Chem Lett 11(4):464\u2013472. https:\/\/doi.org\/10.1021\/acsmedchemlett.9b00566","journal-title":"ACS Med Chem Lett"},{"issue":"4","key":"11405_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1172\/JCI33945","volume":"118","author":"K Stuart","year":"2008","unstructured":"Stuart K, Brun R, Croft S, Fairlamb A, G\u00fcrtler RE, McKerrow J, Reed S, Tarleton R (2008) Kinetoplastids: related protozoan pathogens, different diseases. J Clin Invest 118(4):1301\u20131310. https:\/\/doi.org\/10.1172\/JCI33945","journal-title":"J Clin Invest"},{"key":"11405_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fitd.2023.1087003","volume":"4","author":"R Papagni","year":"2023","unstructured":"Papagni R, Novara R, Minardi ML, Frallonardo L, Panico GG, Pallara E, Cotugno S, Ascoli Bartoli T, Guido G, De Vita E, Ricciardi A, Totaro V, Camporeale M, Segala FV, Bavaro DF, Patti G, Brindicci G, Pellegrino C, Mariani MF, Putoto G, Sarmati L, Castellani C, Saracino A, Di Gennaro F, Nicastri E (2023) Human African trypanosomiasis (sleeping sickness): current knowledge and future challenges. Front Trop Dis 4:1087003. https:\/\/doi.org\/10.3389\/fitd.2023.1087003","journal-title":"Front Trop Dis"},{"issue":"10","key":"11405_CR4","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1039\/C7MD00280G","volume":"8","author":"M Berninger","year":"2017","unstructured":"Berninger M et al (2017) Novel lead compounds in pre-clinical development against African sleeping sickness. MedChemComm 8(10):1872\u20131890. https:\/\/doi.org\/10.1039\/C7MD00280G","journal-title":"MedChemComm"},{"key":"11405_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-3-031-53901-5_4","volume-title":"Neglected tropical diseases-Sub-Saharan Africa","author":"P Lutumba","year":"2024","unstructured":"Lutumba P, Matovu E, Boatin BA (2024) Human African trypanosomiasis (HAT). Neglected tropical diseases-Sub-Saharan Africa. Springer, pp 73\u201397"},{"issue":"2","key":"11405_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/ddr.21664","volume":"83","author":"F Altamura","year":"2022","unstructured":"Altamura F et al (2022) The current drug discovery landscape for trypanosomiasis and leishmaniasis: challenges and strategies to identify drug targets. Drug Dev Res 83(2):225\u2013252. https:\/\/doi.org\/10.1002\/ddr.21664","journal-title":"Drug Dev Res"},{"key":"11405_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2022.128930","volume":"75","author":"PF da Silva Santos-J\u00fanior","year":"2022","unstructured":"da Silva Santos-J\u00fanior PF, da Fernando Silva Santos-J\u00fanior P, Rocha Silva L, Jos\u00e9 Quintans-J\u00fanior L, da Ferreira Silva-J\u00fanior E (2022) Nitro compounds against trypanosomatidae parasites: heroes or villains? Bioorg Med Chem Lett 75:128930. https:\/\/doi.org\/10.1016\/j.bmcl.2022.128930","journal-title":"Bioorg Med Chem Lett"},{"key":"11405_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40265-019-1051-6","volume":"79","author":"ED Deeks","year":"2019","unstructured":"Deeks ED (2019) Fexinidazole: first global approval. Drugs 79:215\u2013220. https:\/\/doi.org\/10.1007\/s40265-019-1051-6","journal-title":"Drugs"},{"issue":"suppl_1","key":"11405_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg212","volume":"51","author":"MI Andersson","year":"2003","unstructured":"Andersson MI, MacGowan AP (2003) Development of the quinolones. JAC 51(suppl_1):1\u201311. https:\/\/doi.org\/10.1093\/jac\/dkg212","journal-title":"JAC"},{"key":"11405_CR10","first-page":"37","volume":"14","author":"L Senerovic","year":"2020","unstructured":"Senerovic L et al (2020) Quinolines and quinolones as antibacterial, antifungal, anti-virulence, antiviral and anti-parasitic agents. Adv Microbiol Infect Dis Public Health: 14:37\u201369","journal-title":"Adv Microbiol Infect Dis Public Health:"},{"issue":"3","key":"11405_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3109\/14756366.2014.930454","volume":"30","author":"S Singh","year":"2015","unstructured":"Singh S et al (2015) Quinoline and quinolones: promising scaffolds for future antimycobacterial agents. J Enzyme inhib Med Chem 30(3):492\u2013504. https:\/\/doi.org\/10.3109\/14756366.2014.930454","journal-title":"J Enzyme inhib Med Chem"},{"issue":"8","key":"11405_CR12","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1128\/AAC.01757-15","volume":"60","author":"G Hiltensperger","year":"2016","unstructured":"Hiltensperger G et al (2016) Quinolone amides as antitrypanosomal lead compounds with in vivo activity. Antimicrob. Agents. Chemother. 60(8):4442\u20134452","journal-title":"Antimicrob. Agents. Chemother."},{"key":"11405_CR13","doi-asserted-by":"publisher","first-page":"115176","DOI":"10.1016\/j.ejmech.2023.115176","volume":"250","author":"J Weinmann","year":"2023","unstructured":"Weinmann J et al (2023) Design, synthesis and biological evaluations of quinolone amides against African trypanosomiasis with improved solubility. Eur J Med Chem 250:115176","journal-title":"Eur J Med Chem"},{"key":"11405_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115539","author":"PS Dube","year":"2023","unstructured":"Dube PS et al (2023) Quinolone analogues of benzothiazinone: synthesis, antitubercular structure-activity relationship and ADME profiling. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115539","journal-title":"Eur J Med Chem"},{"issue":"39","key":"11405_CR15","doi-asserted-by":"publisher","first-page":"13663","DOI":"10.1021\/ja106357w","volume":"132","author":"C Trefzer","year":"2010","unstructured":"Trefzer C et al (2010) Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-\u03b2-D-ribose 2\u2032-epimerase DprE1 of Mycobacterium tuberculosis. J Am Chem Soc 132(39):13663\u201313665. https:\/\/doi.org\/10.1021\/ja106357w","journal-title":"J Am Chem Soc"},{"issue":"8","key":"11405_CR16","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2217\/fmb.11.74","volume":"6","author":"H Cerecetto","year":"2011","unstructured":"Cerecetto H, Gonz\u00e1lez M (2011) Antiparasitic prodrug nifurtimox: revisiting its activation mechanism. Future Microbiol 6(8):847\u2013850. https:\/\/doi.org\/10.2217\/fmb.11.74","journal-title":"Future Microbiol"},{"issue":"2","key":"11405_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijpddr.2015.03.001","volume":"5","author":"J M\u00fcller","year":"2015","unstructured":"M\u00fcller J et al (2015) Comparative characterisation of two nitroreductases from Giardia lamblia as potential activators of nitro compounds. Int J Parasitol Drugs Drug Resist 5(2):37\u201343. https:\/\/doi.org\/10.1016\/j.ijpddr.2015.03.001","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"3","key":"11405_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/biomed4030018","volume":"4","author":"M Fil","year":"2024","unstructured":"Fil M, Alibert S (2024) Unveiling DprE1 as a key target in the fight against tuberculosis: insights and perspectives on developing novel antimicrobial agents. BioMed 4(3):220\u2013236. https:\/\/doi.org\/10.3390\/biomed4030018","journal-title":"BioMed"},{"key":"11405_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2023.129123","volume":"81","author":"KR Francisco","year":"2023","unstructured":"Francisco KR, Monti L, Yang W, Park H, Liu LJ, Watkins K, Amarasinghe DK, Nalli M, Roberto Polaquini C, Regasini LO, Eduardo Miller Crotti A, Silvestri R, Guidi Magalh\u00e3es L, Caffrey CR (2023) Structure-activity relationship of dibenzylideneacetone analogs against the neglected disease pathogen, Trypanosoma brucei. Bioorg Med Chem Lett 81:129123. https:\/\/doi.org\/10.1016\/j.bmcl.2023.129123","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"11405_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202300656","volume":"19","author":"B Lucero","year":"2024","unstructured":"Lucero B et al (2024) Design, synthesis, and evaluation of an anti-trypanosomal [1, 2, 4] triazolo [1, 5-a] pyrimidine probe for photoaffinity labeling studies. ChemMedChem 19(8):e202300656. https:\/\/doi.org\/10.1002\/cmdc.202300656","journal-title":"ChemMedChem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11405-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11405-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11405-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T11:33:02Z","timestamp":1779535982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11405-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["11405"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11405-1","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that they have no known financial or interpersonal conflicts that would have appeared to have an impact on the research presented in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}